Purchase Order 75N93019P00748

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $17,478.36 on November 7, 2018, for HotStartAQ Plus DNA Polymerase (catalog number 203609, quantity 25,000 units) under firm fixed-price pricing. Work is performed in Valencia, California. The order is not set-aside and carries an ultimate completion date of November 25, 2018.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $5,947.89 on January 3, 2018, with ultimate completion on January 28, 2018. The order procures HOTSTARTAQ PLUS DNA Polymerase (5,000 units, catalog #203607) under firm fixed price terms. Place of performance is Valencia, California.</p>

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $140,902.60 firm fixed-price purchase order to Qiagen, LLC to provide 310 kits of HotstarTaq Plus DNA Polymerase. This specialized reagent is used in polymerase chain reaction assays to detect and sequence B cell receptor DNA from human lymphocytes involved in immune responses against HIV and other infectious diseases. The contract has a performance period of...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $17,044.72 firm fixed-price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V. The order is for 2 kits of HOTSTARTAQ DNA POLYMERASE (25000). There is no set-aside designation noted. Qiagen has provided a range of products and services to various federal agencies, including DNA/RNA extraction kits, next-generation sequencing,...

The U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $17,677.70 firm fixed price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The order is for HOTSTARTAQ PLUS DNA POLYMERASE and does not have a set-aside designation. Qiagen, which has provided a range of molecular diagnostics, genomics, and bioinformatics products and services to federal agencies, is...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for DNA polymerase with a ceiling value of $35,250.56 on February 8, 2018, with ultimate completion on February 14, 2019. Place of performance is Carlsbad, California. The order is firm fixed price with no set-aside designation.</p>

This is a firm fixed-price BPA call awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The contract is for the supply of 25,000 units of HotStarTaq DNA Polymerase, a key reagent used in molecular biology and diagnostic applications. The $8,128.31 award was made to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. This contract was not set aside for any specific business...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for a PCR system on March 19, 2020, with a ceiling value of $16,503.50 and ultimate completion date of April 16, 2020. Performance took place in Germantown, Maryland. The order was priced on a firm fixed-price basis with no set-aside applied.</p>

This federal contract award to Qiagen, LLC is a firm-fixed-price BPA call order for the purchase of 4 units of the HOTSTAR TAQ PLUS, CAT# 203607 molecular biology product at $2,079.44 each, for a total ceiling value of $8,034.20. The agency issuing this award is the National Institute of Allergy and Infectious Diseases (NIAID) within the Department of Health and Human Services (HHS). Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which provides a wide range...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $10,736.64 on August 11, 2020. The order covers ten HISPEED Plasmid Maxi Kits at $252.00 each, priced on a firm fixed-price basis. Work is performed in Germantown, Maryland, with an ultimate completion date of September 6, 2020. No small business set-aside applies.</p>